Bvk'S Bioscience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.00 Cr
- Revenue Growth -87.56%
- Profit Growth -79.33%
- Ebitda -79.85%
- Net Worth 1.10%
- Total Assets -45.06%
About Bvk'S Bioscience
Bvk's Bioscience Private Limited (BBPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 May 2015 (Nine years and eight months 8 days old ). Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹2.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Javed Bhimani and Rajeshbhai Daredia serve as directors at the Company.
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24100GJ2015PTC083300
- Company No.
083300
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Bvk'S Bioscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Javed Bhimani  | Additional Director | 18-Oct-2019 | Current |
| Rajeshbhai Daredia | Director | 03-Aug-2019 | Current |
Financial Performance of Bvk'S Bioscience.
Bvk'S Bioscience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 87.56% decrease. The company also saw a substantial fall in profitability, with a 79.33% decrease in profit. The company's net worth moved up by a moderate rise of 1.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bvk'S Bioscience?
In 2023, Bvk'S Bioscience had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Scion Pharma Private LimitedJaved Bhimani and Rajeshbhai Daredia are mutual person
Charges (Loans)
₹0
₹20.00 M
Charges Breakdown by Lending Institutions
- Mehsana Urban Co Op Bank Limited : 1.50 Cr
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2016 | Others | ₹5.00 M | Satisfied |
| 11 Dec 2015 | Mehsana Urban Co Op Bank Limited | ₹1.50 Cr | Satisfied |
How Many Employees Work at Bvk'S Bioscience?
Unlock and access historical data on people associated with Bvk'S Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bvk'S Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bvk'S Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
